Highpoint Pharmaceuticals LLC

Insider Reports History

Location
Lewes, DE
Signature
/s/ Sireesh Appajosyula
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Highpoint Pharmaceuticals LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Hillstream BioPharma Inc. 10%+ Owner Common stock 972,222 $489,028 $0.5030 11 Jan 2022 Direct

Insider Reports Filed by Highpoint Pharmaceuticals LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
THAR Hillstream BioPharma Inc. 11 Jan 2022 0 $0 3 10%+ Owner 11 Jan 2022, 20:45